zonisamide has been researched along with Kidney Failure, Chronic in 1 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Dosage was gradually increased up to 200 to 500 mg/day, and the seizures were controlled satisfactorily." | 1.32 | Dialyzability of the antiepileptic drug zonisamide in patients undergoing hemodialysis. ( Fukuda, F; Ijiri, Y; Inoue, T; Kobayashi, T; Shibahara, N; Suzuki, K; Takenaka, H; Tanaka, K, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ijiri, Y | 1 |
| Inoue, T | 1 |
| Fukuda, F | 1 |
| Suzuki, K | 1 |
| Kobayashi, T | 1 |
| Shibahara, N | 1 |
| Takenaka, H | 1 |
| Tanaka, K | 1 |
1 other study available for zonisamide and Kidney Failure, Chronic
| Article | Year |
|---|---|
Dialyzability of the antiepileptic drug zonisamide in patients undergoing hemodialysis.
Topics: Adult; Anticonvulsants; Anuria; Comorbidity; Drug Administration Schedule; Female; Hemodialysis Solu | 2004 |